Capreomycin Sulfate is a cyclic polypeptide antibiotic that inhibits mycobacterial protein synthesis at the ribosomal level, used as a second-line injectable agent in multidrug-resistant tuberculosis regimens. Simson Pharma's Capreomycin Sulfate reference standard and impurities support the stringent potency and purity testing required of this critical reserve TB drug.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Capreomycin Sulfate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.